 CBS News | Glaxo Drug Faces More Scrutiny Wall Street Journal WASHINGTON—A Senate report that revives concerns about a GlaxoSmithKline PLC diabetes drug's link to heart attacks is putting pressure on ... GlaxoSmithKline, Heineken, Walgreen: US Equity Preview US Senate questions regulators on GSK drug Matthew Herper is a senior editor at Forbes |
Monday, February 22, 2010
Glaxo Drug Faces More Scrutiny - Wall Street Journal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment